Michael Secora serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Michael Secora has executed 90 insider transactions totaling $6.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 11, 2023 involved selling 25,000 shares valued at $171.3K.
Michael Secora currently holds 1,417,131 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Secora has been a net seller of RXRX stock. They have purchased $0 and sold $6.0M worth of shares.
Michael Secora's most recent insider trade was on Oct 11, 2023, when they sold 25,000 shares at $6.85 per share.
Get notified when new Form 4 filings are submitted
| $7.07 |
| Planned |
| Oct 10, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Sep 13, 2023 | RXRX | $217.3K | Sale | 25,000 | $8.69 | Planned |
| Sep 13, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Sep 12, 2023 | RXRX | $210.8K | Sale | 25,000 | $8.43 | Planned |
| Sep 12, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Aug 16, 2023 | RXRX | $222.5K | Sale | 25,000 | $8.90 | Planned |
| Aug 16, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Aug 15, 2023 | RXRX | $43.4K | Payment | 4,727 | $9.19 | Planned |
| Aug 15, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Aug 15, 2023 | RXRX | $231.8K | Sale | 25,000 | $9.27 | Planned |
| Jul 19, 2023 | RXRX | $157.7K | Sale | 9,859 | $16.00 | Planned |
| Jul 19, 2023 | RXRX | $202.0K | Sale | 13,150 | $15.36 | Planned |
| Jul 19, 2023 | RXRX | $28.6K | Sale | 1,991 | $14.36 | Planned |
| Jul 19, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Jul 18, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Jul 18, 2023 | RXRX | $333.7K | Sale | 24,500 | $13.62 | Planned |
| Jul 18, 2023 | RXRX | $7.0K | Sale | 500 | $14.05 | Planned |
| Jun 14, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| Jun 14, 2023 | RXRX | $251.8K | Sale | 25,000 | $10.07 | Planned |
| Jun 13, 2023 | RXRX | $248.3K | Sale | 25,000 | $9.93 | Planned |
| Jun 13, 2023 | RXRX | $83.3K | Option Exercise | 37,500 | $2.22 | Planned |
| May 15, 2023 | RXRX | $26.7K | Payment | 4,760 | $5.60 | Discretionary |
| Feb 15, 2023 | RXRX | $10.6K | Payment | 1,258 | $8.44 | Discretionary |
| Feb 1, 2023 | RXRX | $0 | Award | 202,428 | $N/A | Discretionary |
| Feb 1, 2023 | RXRX | $22.8K | Payment | 2,669 | $8.55 | Discretionary |
| Feb 1, 2023 | RXRX | $0 | Award | 7,735 | $N/A | Discretionary |
| Nov 15, 2022 | RXRX | $12.6K | Payment | 1,065 | $11.86 | Discretionary |
| Aug 15, 2022 | RXRX | $13.8K | Payment | 1,065 | $12.96 | Discretionary |